DNMT3A
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
DNMT3A
Apr 26, 2024, 17:31 |
Insight
Myeloma Paper of the Day, April 26th, suggested by Robert Orlowski
Robert Orlowski, Director of Myeloma Section at MD Anderson Cancer Center, shared on X: "Myeloma…
Mar 31, 2024, 09:02 |
Insight
Yu-Hung Wang: Loss of Dnmt3a increases self-renewal of JAK2V617F HSCs
Yu-Hung Wang, PhD student at The University of Manchester, shared on X/Twitter: “Loss of Dnmt3a…
Sep 21, 2023, 04:23 |
Insight
Asger Jakobsen: How do DNMT3A and TET2 mutant clones impact human haematopoiesis?
Asger Jakobsen, Postdoctoral Clinical Research Fellow at the Radcliffe Department of Medicine, shared on Twitter: "How…
All:
3
Posts:
1 - 10
OncoInfluencers: Dialogue with Rob Pieters, hosted by Shushan Hovsepyan
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Facebook
RSS Feed
Twitter
Linkedin
Youtube